Havas 2015: Blinded Aires Case Study and Cardiovascular Measurements

Magda Havas’s 2015 case report documents improvements in selected cardiovascular pulse-wave measures during radiofrequency exposure with a previous-generation Aires device. The experiment included a placebo device and blinded both the participant and the physician interpreting the orthostatic HRV recordings.

The report connects two questions at the heart of Aires research: how the body responds in an electromagnetic environment, and what changes when Aires technology is introduced. Its measured results give readers a direct route from the research question to the original data.

The participant, exposure and blinded comparison

The participant was a 52-year-old woman who reported electromagnetic hypersensitivity and was taking blood-pressure medication and anticoagulants. Testing took place at Trent University on August 18, 2015; the report is dated August 29.

A 2.4 GHz cordless-phone base generated the RF exposure. After the reference measurements, the study tested RF exposure with the Aires device and RF exposure with a placebo. The placebo consisted of two credit cards matched to the device’s size and weight, placed in the same neck pouch. The participant was blindfolded; the physician interpreting the HRV record did not know the exposure condition.

The cardiovascular findings

Havas reports improvements with the Aires device in selected MaxPulse indices, including differential pulse-wave index, eccentric constriction and arterial elasticity. These are the report’s central cardiovascular findings. The measurements and treatment-by-treatment plots appear in the original report.

The response varied by endpoint and measurement stage. Some scores were best during the later placebo condition, which the author discusses in relation to possible carryover. Orthostatic HRV changed little, and the device did not change heart rate or blood pressure. Keeping these endpoints separate makes the positive pulse-wave results clear rather than relabeling every cardiovascular measurement as an HRV improvement.

The report also describes changes in the appearance of red-blood-cell aggregation in live-blood microscopy and the participant’s reported experience. These observations are documented alongside the instrument readings in the original.

Biological measurements beyond an EMF-meter reading

The external RF and low-frequency field measurements did not fall with the device. Havas nevertheless reported changes in selected physiological measurements. That combination is directly relevant to the Aires approach: the research question extends beyond whether a meter shows less field strength to how biology responds when the technology is present.

Follow the connected research

The second 2015 Havas case report tested another participant with a router, cordless-phone base and baby monitor. It reports further pulse-wave findings using its own exposure sequence. Read both reports as individually documented investigations within the wider cardiovascular program.

Explore cardiovascular and HRV research, home EMF planning and how Aires research connects to the technology. The study used a previous-generation Aires device; the original report identifies the tested configuration.

Related source records and guides

Updated November 2, 2026 · Josh, Aires. Original research and peer reviews remain attributed to their authors and linked above.